News-Papers
Testimonial
Video Gallery
Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase
Published on Wednesday, 02 May 2018
Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase
See also:
- Somatostatin in oncology, the overlooked evidences;
- The Di Bella Method (A Fixed Part - Somatostatin, Octreotide, LAR analogues and/or derivatives);
- Pancreatic Adenocarcinoma: clinical records on 17 patients treated with Di Bella's Method;
- Complete objective response to biological therapy of plurifocal breast carcinoma.
Search
Follow us...
Latest
- Melatonin induces apoptosis in human neuroblastoma cancer cells
- Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
- Melatonin inhibits growth of B16 melanoma in C57BL/6 mice
- Somatostatin in oncology, the overlooked evidences
- Complete objective response of neuroblastoma to biological treatment
- Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status
- Radio-protective effects of melatonin against irradiation-induced oxidative damage in rat peripheral blood
- Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
- Melatonin, mitochondria, and the cancer cell
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
- Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells
- Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts
- Melatonin: reducing the toxicity and increasing the efficacy of drugs
- Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro
- Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
- Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
- Molecular aspects of melatonin (MLT)-mediated therapeutic effects
- Molecular mechanisms of melatonin anticancer effects
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer